Sara Silbert
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
-
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 16
- CAR-T cell therapy research 16
-
- Acute Lymphoblastic Leukemia research 6
- Co-authors
- Nirali N. Shah (15 shared papers)Craig S. Sauter (1 shared paper)Carlos A. Ramos (1 shared paper)Mohamed Abou‐El‐Enein (1 shared paper)Loretta J. Nastoupil (1 shared paper)Leila Amini (1 shared paper)Renier J. Brentjens (1 shared paper)Shannon L. Maude (1 shared paper)
- Journals
- Transplantation and Cellular Therapy (4 papers)Blood (3 papers)Blood Advances (3 papers)Pediatric Blood & Cancer (2 papers)British Journal of Haematology (1 paper)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
Sara Silbert
14 papers receiving 290 citations
Sara Silbert's Hit Papers
Peers
Comparison fields: 5 of 33
- Oncology 244
- Immunology 67
- Genetics 46
- Biomedical Engineering 66
- Molecular Biology 75
Countries citing papers authored by Sara Silbert
This map shows the geographic impact of Sara Silbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Silbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Silbert more than expected).
Fields of papers citing papers by Sara Silbert
This network shows the impact of papers produced by Sara Silbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Silbert. The network helps show where Sara Silbert may publish in the future.
Co-authors
The 25 scholars most cited alongside Sara Silbert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion Hit paper breakdown → | 2022 | 225 |
| 2 | 2022 | 22 | |
| 3 | 2019 | 13 | |
| 4 | 2024 | 9 | |
| 5 | 2024 | 8 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 4 | |
| 8 | 2022 | 2 | |
| 9 | 2023 | 2 | |
| 10 | 2024 | 2 | |
| 11 | 2025 | 1 | |
| 12 | 2024 | 1 | |
| 13 | 2025 | 1 | |
| 14 | 2023 | 1 | |
| 15 | 2026 | 0 | |
| 16 | 2025 | 0 | |
| 17 | 2025 | 0 | |
| 18 | 2024 | 0 | |
| 19 | 2026 | 0 | |
| 20 | 2025 | 0 |
About Sara Silbert
Sara Silbert is a scholar working on Oncology, Public Health, Environmental and Occupational Health, Genetics, Hematology and Physiology, having authored 20 papers that have together received 296 indexed citations. Recurring topics across this work include CAR-T cell therapy research (16 papers), Acute Lymphoblastic Leukemia research (6 papers), Acute Myeloid Leukemia Research (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Integrated Circuits and Semiconductor Failure Analysis (2 papers), Biomedical Ethics and Regulation (2 papers), Advancements in Semiconductor Devices and Circuit Design (2 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Oncology (244 citations), Immunology (67 citations), Genetics (46 citations), Biomedical Engineering (66 citations) and Molecular Biology (75 citations). Sara Silbert has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include Nirali N. Shah, Craig S. Sauter, Carlos A. Ramos, Mohamed Abou‐El‐Enein, Loretta J. Nastoupil, Leila Amini, Renier J. Brentjens, Shannon L. Maude, Andrew G. Shuman and Bonnie Yates. Their work appears in journals such as Transplantation and Cellular Therapy, Blood, Blood Advances, Pediatric Blood & Cancer and British Journal of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.